The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters.
about
Lipid-lowering efficacy of atorvastatinLipid lowering efficacy of atorvastatinPharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery DiseaseImplications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemiaPharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients.The Effect of Date Seed (Phoenix dactylifera) Extract on Paraoxonase and Arylesterase Activities in Hypercholesterolemic Rats.The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways.Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit.Drug-induced long QT syndrome and drug development.No clinically relevant drug-drug interactions when dalcetrapib is co-administered with atorvastatin.PON1 status evaluation in patients with chronic arterial occlusion of lower limbs due to atherosclerosis obliterans.Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.Ameliorative effect of statin therapy on oxidative damage in heart tissue of hypercholesterolemic rabbits.Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes
P2860
Q24187301-4082E949-EF65-48DC-AC04-8BAA5B4E9588Q24202363-C06E5693-4AFE-43B5-9FF4-252D44447D06Q34796636-F028CB96-D1D1-432C-98B0-0C691A5764CAQ36366974-910D7BD0-E701-419C-AF12-2D8FCE69E434Q37015961-A3CC1393-E7FB-4FC1-8FA8-1243BDD5FEA0Q37463147-AFF66844-7803-4D68-B8E5-E2E9170F1D4AQ38016347-5B422C15-4BA3-4E81-B1C7-4E2885191A7CQ38309993-F84C57D9-3DA5-45B6-A1DB-40A235FE81CAQ39883075-48B6C861-6F10-4F3C-9517-E9A1C94F5C70Q40793611-D5A3DFAE-9351-440E-BDB1-3299F1944600Q41115717-23AF3B51-C99F-4B60-BA9C-D31741DE0F75Q42419522-5EF03FBF-85A6-4D15-BBB9-5EBA0ABCD27FQ42926221-7D7BBF06-8B74-4C87-9BBF-84F490B82D80Q43107935-5BB5D7CF-CDF4-4159-A959-FAFA496997F3Q47857122-DCB6EE69-818B-4E9D-9FB9-30EF6583BAC1Q47980523-77049D09-E7E0-46EF-9B03-7E00B07F44A9Q53664550-2098CD0E-DEC8-4A26-B6AB-D774DFC6F987Q57147406-6DAEB593-714E-4D7C-8EBE-44D1459B022F
P2860
The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The human paraoxonase-1 phenot ...... activity and lipid parameters.
@en
type
label
The human paraoxonase-1 phenot ...... activity and lipid parameters.
@en
prefLabel
The human paraoxonase-1 phenot ...... activity and lipid parameters.
@en
P2093
P2860
P1476
The human paraoxonase-1 phenot ...... activity and lipid parameters.
@en
P2093
Ferenc Sztanek
György Paragh
Hossein Z Mirdamadi
Ildiko Seres
Mariann Harangi
Zoltan Derdak
P2860
P304
P356
10.1111/J.1365-2125.2008.03213.X
P407
P577
2008-09-01T00:00:00Z